Vesencumab (Anti-NRP1 / VEGF165R / CD304), 1mg*5

Vesencumab (Anti-NRP1 / VEGF165R / CD304), 1mg*5

Tavolixizumab (Anti-TNFRSF4 / OX40 / CD134), 1mg

Tavolixizumab (Anti-TNFRSF4 / OX40 / CD134), 1mg

Vesencumab (Anti-NRP1 / VEGF165R / CD304), 1mg*25

27.059,41 RON
SKU
SKM_A2682_1mg*25

Vesencumab (Anti-NRP1 / VEGF165R / CD304) is an IG1 antibody targeting neuropilin-1 (NRP-1). It has anti-angiogenic and anti-neoplastic activities and can be used in the research of metastatic solid tumors, including ovarian cancer and Diabetic macular edema (DME). MW :150 KD.

Mai multe informatii
Price 22.739,00 RON (preturile sunt fara TVA)
Description

Vesencumab (Anti-NRP1 / VEGF165R / CD304) is an IG1 antibody targeting neuropilin-1 (NRP-1). It has anti-angiogenic and anti-neoplastic activities and can be used in the research of metastatic solid tumors, including ovarian cancer and Diabetic macular edema (DME). MW :150 KD.